EA202191605A1 - ANTIBODIES TO PERIOSTIN AND THEIR APPLICATION - Google Patents

ANTIBODIES TO PERIOSTIN AND THEIR APPLICATION

Info

Publication number
EA202191605A1
EA202191605A1 EA202191605A EA202191605A EA202191605A1 EA 202191605 A1 EA202191605 A1 EA 202191605A1 EA 202191605 A EA202191605 A EA 202191605A EA 202191605 A EA202191605 A EA 202191605A EA 202191605 A1 EA202191605 A1 EA 202191605A1
Authority
EA
Eurasian Patent Office
Prior art keywords
periostin
antibodies
application
application describes
tumor
Prior art date
Application number
EA202191605A
Other languages
Russian (ru)
Inventor
Ариф Джетха
Йохан Франссон
ЭйДжей Роберт Макгрей
Джоанн Хьюм
Original Assignee
Бёрингер Ингельхайм Ио Канада Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Ио Канада Инк. filed Critical Бёрингер Ингельхайм Ио Канада Инк.
Priority claimed from PCT/IB2019/001307 external-priority patent/WO2020121059A1/en
Publication of EA202191605A1 publication Critical patent/EA202191605A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

В данной заявке описываются антитела, которые блокируют функции периостина. Также в данной заявке описывается их применение для лечения рака и модификации иммунных свойств опухоли.This application describes antibodies that block the function of periostin. Also in this application describes their use in the treatment of cancer and modification of the immune properties of the tumor.

EA202191605A 2019-09-11 2019-12-13 ANTIBODIES TO PERIOSTIN AND THEIR APPLICATION EA202191605A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962899075P 2019-09-11 2019-09-11
PCT/IB2019/001307 WO2020121059A1 (en) 2018-12-14 2019-12-13 Anti-periostin antibodies and uses thereof

Publications (1)

Publication Number Publication Date
EA202191605A1 true EA202191605A1 (en) 2021-11-10

Family

ID=78768144

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191605A EA202191605A1 (en) 2019-09-11 2019-12-13 ANTIBODIES TO PERIOSTIN AND THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA202191605A1 (en)

Similar Documents

Publication Publication Date Title
EA201892294A1 (en) ANTIBODIES AND COMPOSITIONS AGAINST TIM-3
PH12020500671A1 (en) Antibodies specific for gucy2c and uses thereof
MX2021012134A (en) Immune modulation and treatment of solid tumors with antibodies that specifically bind cd38.
MX2020012797A (en) Anti-pvrig/anti-tigit bispecific antibodies and methods of use.
MX2019012233A (en) Anti-sirp alpha antibodies.
CO2021001912A2 (en) Anti-cd112r compositions and methods
EA202090104A1 (en) ANTIBODY MOLECULES TO CD73 AND WAYS OF THEIR APPLICATION
EA202092306A1 (en) ANTI-CD24 COMPOSITIONS AND THEIR APPLICATIONS
EA201691824A1 (en) ANTIBODIES AGAINST EGFRVIII AND THEIR APPLICATIONS
EA202091540A1 (en) ANTIBODIES TO LILRB2
EA201790413A1 (en) ANTIBODIES AGAINST TIGIT
PH12020552229A1 (en) Il-11ra antibodies
MX2020009861A (en) Antibodies against mica and/or micb and uses thereof.
EA201990296A1 (en) ANTIBODIES AGAINST SIGLEC-7 FOR CANCER TREATMENT
MX2021001268A (en) Anti-btn3a antibodies and their use in treating cancer or infectious disorders.
MX2020008122A (en) Anti-pd-1 antibodies.
EA202191257A1 (en) ANTI-CANCER THERAPY BASED ON IMMUNOCYTES BINDING LIV1
MX2020003219A (en) Antibodies having specificity for btn2 and uses thereof.
EA202190862A1 (en) METHODS OF TREATMENT
EA201791819A1 (en) COMBINED THERAPY WITH ANTIBODY CONJUGATE AGAINST CD19 WITH MEDICINE AND VINCRISTINE
CR20210310A (en) Anti-periostin antibodies and uses thereof
PH12020551968A1 (en) Anti-sez6 antibody drug conjugates and methods of use
EA202191081A1 (en) NEW CANCER ANTIGENS AND ACCOMPANYING METHODS
EA202191605A1 (en) ANTIBODIES TO PERIOSTIN AND THEIR APPLICATION
MX2021001604A (en) Cancer treatment with an antibody.